<SEC-DOCUMENT>0001213900-22-068433.txt : 20230728
<SEC-HEADER>0001213900-22-068433.hdr.sgml : 20230728
<ACCEPTANCE-DATETIME>20221102094048
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001213900-22-068433
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20221102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTENSITY THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001567264
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				461488089
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		61 WILTON ROAD, 3RD FLOOR
		CITY:			WESTPORT
		STATE:			CT
		ZIP:			06880
		BUSINESS PHONE:		203-221-7381

	MAIL ADDRESS:	
		STREET 1:		61 WILTON ROAD, 3RD FLOOR
		CITY:			WESTPORT
		STATE:			CT
		ZIP:			06880

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Intensity Therapeutics, Inc.
		DATE OF NAME CHANGE:	20130117
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt"><IMG SRC="image_001.jpg" ALT=""></TD>
    <TD STYLE="width: 50%; text-align: right; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>mwe.com</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">November 2, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>VIA EDGAR AND EMAIL</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">U.S. Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jane Park</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suzanne Hayes</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sasha Parikh</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Al Pavot</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 6%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD STYLE="width: 84%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Intensity Therapeutics, Inc.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Amendment No. 9 to Registration Statement on
    Form S-1</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Filed October 3, 2022</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>File No. 333-260565</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Ms. Park:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On behalf of Intensity Therapeutics, Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), we are responding to the comments from the Staff (the &ldquo;<B>Staff</B>&rdquo;) of the
Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) dated October 31, 2022 (the &ldquo;<B>Comment Letter</B>&rdquo;),
relating to the above referenced Registration Statement on Form S-1 (File No. 333-260565) filed by the Company on October 3, 2022 (the
&ldquo;<B>Registration Statement</B>&rdquo;). In response to the comments set forth in the Comment Letter, the Company has revised the
Registration Statement and is filing it with the Commission together with its submission of this response letter. Set forth below is the
Company&rsquo;s response to the Staff&rsquo;s comments. For convenience, the Staff&rsquo;s comments are repeated below in bold, followed
by the Company&rsquo;s response.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Amendment No. 9 to Form S-1 filed October 3,
2022</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Cover Page</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclose whether your offering is contingent upon final approval of your Nasdaq listing on your cover page. Please ensure the disclosure is consistent with your underwriting agreement.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Response</U>: In response to the Staff&rsquo;s
comment, the Company has revised its disclosure on the cover page and pages 1, 4, 6, 31, 118 and 126 of the revised Registration Statement.
We have also revised Sections 2.2 and 8.2 of the underwriting agreement to clarify that the offering is contingent upon final approval
of our Nasdaq listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Risk Factors, page 9</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We note recent instances of extreme stock price run-ups followed by rapid price declines and stock price volatility seemingly unrelated to company performance following a number of recent initial public offerings, particularly among companies with relatively smaller public floats. Revise to include a separate risk factor addressing the potential for rapid and substantial price volatility and any known factors particular to your offering that may add to this risk and discuss the risks to investors when investing in stock where the price is changing rapidly. Clearly state that such volatility, including any stock run-up, may be unrelated to your actual or expected operating performance and financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of your stock. </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Response</U>: In response to the Staff&rsquo;s
comment, the Company has revised pages 3 and 9 of the revised Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please contact me at +1 212 547 5553 if you have
any questions or require any additional information in connection with this letter or the Company&rsquo;s submission of its revised Registration
Statement on Form S-1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Daniel Woodard</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cc: Lewis Bender, Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !I &H# 2(  A$! Q$!_\0
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M[<7B5AXQD]FTGZ'H.M:3#K>ES64W <95NZL.AKPV\M);"\FM9UVS1L58>_\
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+T45F>D%%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
